Menu

Home

Genetic Testing

Drug Development

References

 

References

[1] J. Oldenburg, M. W. S. R. C. R. M. (2007). "VKORC1: molecular target of coumarins." Journal of Thrombosis and Haemostasis 5(s1): 1-6.

[2] Kalow, W. (2006). "Pharmacogenetics and pharmacogenomics: origin, status, and the hope for personalized medicine." Pharmacogenomics J 6(3): 162-165.

[3] Kirchheiner, J. and J. Brockmoller (2005). "Clinical Consequences of Cytochrome P450 2C9 Polymorphisms." Clin Pharmacol Ther 77(1): 1-16.

[4] Lee, S. S.-J. and A. Mudaliar (2009). "MEDICINE: Racing Forward: The Genomics and Personalized Medicine Act." Science 323(5912): 342-.

[5] Reitman, M. L. (2007). "Pharmacogenetics of metformin response: a step in the path toward personalized medicine." The Journal of Clinical Investigation 117(5): 1226-1229.

[6] Shastry, B. S. (2005). "Pharmacogenetics and the concept of individualized medicine." Pharmacogenomics J 6(1): 16-21.